Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab
Abstract
We report a case of a 53-year-old male patient with melanoma who was treated with combination immune checkpoint blockade (ICB) with ipilimumab and nivolumab. The patient had advanced disease with metastasis to the liver, lung, and lymph nodes. After two doses of ICB, the patient developed hypocalcemia as a result of an immune-mediated hypoparathyroidism that was treated with calcium and vitamin D substitution. In addition, the patient suffered...
Paper Details
Title
Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab
Published Date
Jul 15, 2019
Journal
Volume
42
Issue
9
Pages
e153 - e154
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History